Pharmacy gains as preferred flu shot venue
One important finding from a recent online survey of more than 900 AccentHealth viewers conducted in September confirmed that more patients continue to embrace the community pharmacy as a preferred destination for flu vaccinations. Nearly 1-in-4 said they have received or plan to receive a flu shot this year in a retail pharmacy setting — up four percentage points from a year ago.
To see more Patient Views, click here.
Patient Views is an exclusive consumer insights feature that appears in every edition of DSN A.M., and every issue of DSN magazine. If you could ask 4,000 patients anything at all, what would it be? Send your questions to [email protected].
Source: AccentHealth. To view the demographic breakdown of participants, click here.
Pharmacist care for patients has grown, study finds
NEW YORK — About two-fifths of pharmacists say they spend more time providing care and support for patients than they did two years ago, according to a new study from a market research and advisory firm.
Manhattan Research released the results of its "Taking the Pulse Pharmacists 2012" study, which surveyed 752 U.S. pharmacists online in September and October about their use of various channels and sources, including digital content and mobile devices for professional purposes and patient care.
"Pharmacists are stepping outside their traditional roles and are increasingly providing patient care services supplemented by the vast array of digital information and tools at their disposal," Manhattan Research principal analyst Shawn Dimantha said. "As primary care providers struggle to meet patient demand, pharmacists will play a growing role as an alternative point of care."
The top disease states for which retail pharmacists provided the most care and support were diabetes, cardiovascular disorders, pain, respiratory diseases, and psychosis and depression, according to the study, which also found that pharmacists would like drug companies to provide them with online access to resources to help them support patients. For example, more than three-quarters of pharmacists would like access to online patient education materials, while 64% of retail pharmacists would like patient assistance or vouchers.
Teva appoints new president and CEO for North American generics business
JERUSALEM — Teva Pharmaceutical Industries has made some new executive appointments, the drug maker said Tuesday.
Teva promoted Allan Oberman, currently SVP North America generic pharmaceuticals, to president and CEO of Teva Americas Generics. In the new role, Oberman will report directly to Teva president and CEO Jeremy Levin and have continued responsibility for generics in the North American market and overall management of the company’s Latin American businesses.
Jill DeSimone was appointed to the newly created position of SVP and general manager of Teva Global Women’s Health and will oversee all aspects of the company’s women’s health franchise.
Meanwhile, William Marth is stepping down as president and CEO of Teva Americas, effective immediately, and will retire at the end of 2013. Until his retirement, Marth will serve as a senior adviser to Levin.
"These changes are part of our ongoing process to build a premier leadership team and reshape Teva," Levin said. "Allan brings extensive experience in global generics to the company’s Americas teams. Jill brings a great track record and many years of experience in building franchises in specialty medicine. We look forward to her contributions in leading our women’s health business."